Inventor
JINGXIN LIANG
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides40%
G01NInvestigating or analysing materials by determining their chemical or physical properties30%
A61KPreparations for medical, dental or toiletry purposes10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
PatentTitleYear
12,546,785IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making202612,517,136Il-17F-specific capture agents, compositions, and methods of using and making202612,139,502Aromatic boron-containing compounds and related insulin analogs202411,719,705IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to CALIFORNIA INST OF TECHN (3)· patent assignee history
2023Patents assigned to INDI MOLECULAR INC (1)· patent assignee history
2023–2026Based in US· patent location history
2024Patents assigned to PROTOMER TECH INC (1)· patent assignee history
2026Patents assigned to REGENERON PHARMA (2)· patent assignee history
2026Patents assigned to REGENERON (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CALIFORNIA INST OF TECHN | 3 | 2023–2026 |
| REGENERON PHARMA | 2 | 2026 |
| INDI MOLECULAR INC | 1 | 2023 |
| PROTOMER TECH INC | 1 | 2024 |
| REGENERON | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2026 |